Instrument Inactif

Autres langues Axovant Sciences Ltd Nyse

Actions

AXON

BMG0750W1047

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	02/02
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	02/02
SIO GENE THERAPIES INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	06/04/23
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from S&P TMI Index	27/03/23
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from NASDAQ Composite Index	22/03/23
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	15/03/23
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	15/03/23
SIO GENE THERAPIES INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	14/02/23
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/02/23
Sio Gene Therapies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23
Sio Gene Therapies Board Approves Plan of Liquidation, Dissolution; Shares Rise After Hours	14/12/22
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution	14/12/22
Sio Gene Therapies : Announces Board Approval of Plan of Complete Liquidation and Dissolution - Form 8-K	14/12/22
SIO GENE THERAPIES INC. : Other Events, Financial Statements and Exhibits (form 8-K)	14/12/22
SIO GENE THERAPIES INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10/11/22
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10/11/22
Sio Gene Therapies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/11/22
Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results	10/11/22
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	14/09/22
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	14/09/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Axovant Sciences Ltd Nyse

Actions

AXON

BMG0750W1047

Autres langues

Filtres